Literature DB >> 27215911

Brain arteriovenous malformations: implications of CEACAM1-positive inflammatory cells and sex on hemorrhage.

Belal Neyazi1, Angelika Herz1, Klaus-Peter Stein1, Islam Gawish1, Christian Hartmann2, Ludwig Wilkens3, Sueleyman Erguen4, Claudia A Dumitru1, I Erol Sandalcioglu5.   

Abstract

Brain arteriovenous malformations (bAVMs) are severe conditions which, upon rupture, cause debilitating neurological deficits and even death. The exact cellular and molecular mechanisms associated with bAVM rupture are currently unclear. The objective of this study was to explore the potential role of CEA-related cell adhesion molecule-1 (CEACAM1) in bAVM pathophysiology. Expression and localization of CEACAM1 were assessed immunohistochemically in tissue microarrays from bAVM patients (n = 60). The association of CEACAM1 with clinical parameters was analyzed with Spearman's rank correlation coefficient and chi-square test. The predictive value of CEACAM1 was tested using logistic regression analysis. CEACAM1 was highly expressed in tissue-infiltrating neutrophil granulocytes. High levels of CEACAM1-positive cells were associated with bAVM rupture (hemorrhage), but not with arteriovenous malformation (AVM) size, preoperative embolization, or seizure. This association was significant (p = 0.029, chi-square) in male but not in female patients, and high CEACAM1-positive immune infiltration showed predictive significance for hemorrhage in male bAVM patients only (OR = 6.50, 95 % CI 1.09-38.63, p = 0.040). Within the ruptured bAVM group, patients with a short hemorrhage to surgery (HTS) time interval had higher levels of CEACAM1 immune infiltration than patients with long HTS. This decrease in the levels of CEACAM1 immune infiltration between the HTS short and HTS long groups was, however, significant only in female patients (p = 0.022, chi-square). Our findings substantiate the role of inflammation in the pathophysiology of bAVM and suggest the presence of sexual dimorphism in this disease.

Entities:  

Keywords:  Brain arteriovenous malformations; CEACAM1; Hemorrhage; Inflammation; Sexual dimorphism

Mesh:

Substances:

Year:  2016        PMID: 27215911     DOI: 10.1007/s10143-016-0744-5

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  22 in total

Review 1.  Arteriovenous malformations: epidemiology and clinical presentation.

Authors:  Aki Laakso; Juha Hernesniemi
Journal:  Neurosurg Clin N Am       Date:  2012-01       Impact factor: 2.509

2.  CEACAM1 expression in oligodendrocytes of the developing rat brain shows a spatiotemporal relation to myelination and is altered in a model of encephalopathy of prematurity.

Authors:  Sebastian Prager; Bernhard B Singer; Ivo Bendix; Gerald W Schlager; Frederik Bertling; Burcin Ceylan; Matthias Keller; Ursula Felderhoff-Mueser; Süleyman Ergün
Journal:  Dev Neurosci       Date:  2013-05-03       Impact factor: 2.984

3.  CEACAM1 (CD66a) mediates delay of spontaneous and Fas ligand-induced apoptosis in granulocytes.

Authors:  Bernhard B Singer; Esther Klaile; Inka Scheffrahn; Mario M Müller; Robert Kammerer; Werner Reutter; Björn Obrink; Lothar Lucka
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

4.  Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils.

Authors:  E Feuk-Lagerstedt; E T Jordan; H Leffler; C Dahlgren; A Karlsson
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

Review 5.  Arteriovenous malformations.

Authors:  Ian G Fleetwood; Gary K Steinberg
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

Review 6.  Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes.

Authors:  Mathew J Reeves; Cheryl D Bushnell; George Howard; Julia Warner Gargano; Pamela W Duncan; Gwen Lynch; Arya Khatiwoda; Lynda Lisabeth
Journal:  Lancet Neurol       Date:  2008-08-21       Impact factor: 44.182

7.  Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.

Authors:  Peter Ludewig; Jan Sedlacik; Mathias Gelderblom; Christian Bernreuther; Yücel Korkusuz; Christoph Wagener; Christian Gerloff; Jens Fiehler; Tim Magnus; Andrea Kristina Horst
Journal:  Circ Res       Date:  2013-06-18       Impact factor: 17.367

8.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321

9.  AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma.

Authors:  Claudia A Dumitru; Agnes Bankfalvi; Xiang Gu; Reinhard Zeidler; Sven Brandau; Stephan Lang
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

10.  Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior.

Authors:  Harrison T Muturi; Janine D Dreesen; Elena Nilewski; Holger Jastrow; Bernd Giebel; Suleyman Ergun; Bernhard B Singer
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more
  5 in total

1.  Virulence Traits of a Serogroup C Meningococcus and Isogenic cssA Mutant, Defective in Surface-Exposed Sialic Acid, in a Murine Model of Meningitis.

Authors:  Roberta Colicchio; Chiara Pagliuca; Susanna Ricci; Elena Scaglione; Denis Grandgirard; Ilias Masouris; Fabrizio Farina; Caterina Pagliarulo; Giuseppe Mantova; Laura Paragliola; Stephen L Leib; Uwe Koedel; Gianni Pozzi; Pietro Alifano; Paola Salvatore
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

2.  Potential Targets for the Treatment of Brain Arteriovenous Malformations.

Authors:  Alka Yadav; Hua Su
Journal:  Transl Stroke Res       Date:  2022-06-20       Impact factor: 6.800

3.  Grades of brain arteriovenous malformations and risk of hemorrhage and death.

Authors:  Marco A Stefani; Diego Sgarabotto Ribeiro; Jay P Mohr
Journal:  Ann Clin Transl Neurol       Date:  2019-01-22       Impact factor: 4.511

4.  Histopathology of brain AVMs part II: inflammation in arteriovenous malformation of the brain.

Authors:  Roosa Wright; Patrik Järvelin; Henri Pekonen; Sara Keränen; Tuomas Rauramaa; Juhana Frösen
Journal:  Acta Neurochir (Wien)       Date:  2020-04-18       Impact factor: 2.216

Review 5.  Recent progress understanding pathophysiology and genesis of brain AVM-a narrative review.

Authors:  Hans-Jakob Steiger
Journal:  Neurosurg Rev       Date:  2021-04-10       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.